🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Prospective, non-interventional study in patients with CSU where the treatm...
Status
Recruiting
Location
Cleaver Dermatology
Start Date
2026-02-02
Trial ID
NCT07358780
A study to evaluate the efficacy, safety and tolerability of Remibrutinib v...
Status
Recruiting
Location
Neuromuscular Research Center
Start Date
2025-02-07
Trial ID
NCT06744920
Treatments Being Tested
A study to evaluate the safety, efficacy and tolerability of remibrutinib a...
Status
Completed
Location
Allervie Clinical Research
Start Date
2022-10-12
Trial ID
NCT05432388
To compare the efficacy and safety of remibrutinib versus teriflunomide in ...
Status
Active Not Recruiting
Location
AZ Integrated Neuro and Spine
Start Date
2021-12-16
Trial ID
NCT05147220
Treatments Being Tested
The purpose of this phase 3 study is to establish the efficacy, safety and ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-14
Trial ID
NCT07700056
Treatments Being Tested
The study is an investigator-run, study following participants for 2 years ...
Status
Not Yet Recruiting
Location
Cleveland Clinic
Start Date
2027-03-01
Trial ID
NCT07222956
Treatments Being Tested
The main purpose of this study is to assess preliminary efficacy and safety...
Status
Active Not Recruiting
Location
Olympian Clinical Research
Start Date
2019-02-27
Trial ID
NCT03827798
Prospective, multi-country, non-interventional study in patients with CSU w...
Status
Recruiting
Location
Cleaver Dermatology
Start Date
2026-02-02
Trial ID
NCT07358364
The purpose of this study was to assess the effect of remibrutinib 25 mg tw...
Status
Completed
Location
Acuro Research Inc
Start Date
2023-04-05
Trial ID
NCT05795153
Treatments Being Tested
The purpose of this study was to evaluate the safety, tolerability and effi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2022-01-15
Trial ID
NCT05048342
Treatments Being Tested